OncoCyte Corp (OCX)
2.84
+0.18
(+6.77%)
USD |
NASDAQ |
May 06, 16:00
2.84
0.00 (0.00%)
After-Hours: 20:00
OncoCyte Cash from Investing (Quarterly): 0.241M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.241M |
| September 30, 2023 | -1.296M |
| June 30, 2023 | 0.123M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.802M |
| September 30, 2022 | -0.859M |
| June 30, 2022 | -1.118M |
| March 31, 2022 | -1.561M |
| December 31, 2021 | -0.401M |
| September 30, 2021 | -0.394M |
| June 30, 2021 | -4.894M |
| March 31, 2021 | -8.272M |
| December 31, 2020 | -0.498M |
| September 30, 2020 | -0.526M |
| June 30, 2020 | -4.533M |
| March 31, 2020 | -6.191M |
| December 31, 2019 | -1.216M |
| September 30, 2019 | -11.24M |
| Date | Value |
|---|---|
| June 30, 2019 | -0.011M |
| March 31, 2019 | 0.047M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.009M |
| June 30, 2018 | -0.017M |
| March 31, 2018 | -0.005M |
| December 31, 2017 | -0.006M |
| September 30, 2017 | -0.03M |
| June 30, 2017 | 0.393M |
| March 31, 2017 | 0.486M |
| December 31, 2016 | -0.108M |
| September 30, 2016 | -0.009M |
| June 30, 2016 | -0.049M |
| March 31, 2016 | -0.015M |
| December 31, 2015 | 0.282M |
| September 30, 2015 | 0.044M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.011M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-11.24M
Minimum
Sep 2019
0.241M
Maximum
Dec 2023
-2.286M
Average
-0.859M
Median
Sep 2022
Cash from Investing (Quarterly) Benchmarks
| Fonar Corp | -0.133M |
| XWELL Inc | 6.822M |
| ProPhase Labs Inc | -1.264M |
| Applied DNA Sciences Inc | 0.00 |
| Veracyte Inc | -2.497M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.562M |
| Cash from Financing (Quarterly) | -0.03M |
| Free Cash Flow | -23.61M |
| Free Cash Flow Per Share (Quarterly) | -0.5838 |
| Free Cash Flow to Equity (Quarterly) | -4.826M |
| Free Cash Flow Yield | -108.7% |